Quest for effective agents to combat T-cell acute lymphoblastic leukemia

European Journal of Cancer

Volumn 41, Issue 9, 2005, Pages 1243-1245

  Pui, Ching Hon ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 MERCAPTOPURINE DERIVATIVE; ANTILEUKEMIC AGENT; ASPARAGINASE; CISPLATIN; DAUNORUBICIN; GAMMA SECRETASE INHIBITOR; GUANINE ARABINOSIDE; IFOSFAMIDE; IMATINIB; LY 411575; METHOTREXATE; PREDNISOLONE; UNCLASSIFIED DRUG; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; CELL TRANSFORMATION; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG SENSITIVITY; HUMAN; LEUKEMOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RISK ASSESSMENT; SHORT SURVEY;

EID: 20444441563     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2005.03.008     Document Type: Editorial

References (16)

1. J.M. Goldberg, L.B. Silverman, and D.E. Levy Childhood T-cell acute lymphoblastic leukemia: The Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience J Clin Oncol 21 2003 3616 3622
2. C.-H. Pui, J.T. Sandlund, and D. Pei Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St. Jude Children's Research Hospital Blood 104 2004 2690 2696
3. Kaspers GJL, Wijnands JJM, Hartmann R, et al. Immunophenotypic cell lineage and in vitro cellular drug resistance in childhood relapsed acute lymphoblastic leukaemia. Eur J Cancer this issue (doi:10.1016/j.ejca.2005.02. 026)
4. A. Holleman, M.H. Cheok, and M.L. den Boer Gene-expression patterns in drug-resistance acute lymphoblastic leukemia cells and response to treatment N Engl J Med 351 2004 533 542
5. R. Pieters, M.L. den Boer, and M. Durian Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia-implications for treatment of infants Leukemia 12 1998 1344 1348
6. L. Kager, M. Cheok, and W. Yang Folate pathway gene expression differs in subtypes of acute lymphoblastic leukemia and influences methotrexate pharmacodynamics J Clin Invest 115 2005 110 117
7. C.-H. Pui, S. Sallan, and M.V. Relling International childhood acute lymphoblastic leukemia workshop: Sausalito, CA, 30 November-1 December 2000 Leukemia 15 2001 707 715
8. M.D. Amylon, J. Shuster, and J. Pullen Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study Leukemia 13 1999 335 342
9. V. Gandhi, W. Plunkett, and C.O. Rodriguez Jr. Compound GW506U78 in refractory hematologic malignancies: relationship between cellular pharmacokinetics and clinical response J Clin Oncol 16 1998 3607 3615
10. C.-H. Pui, M.V. Relling, and J.R. Downing Acute lymphoblastic leukemia N Engl J Med 350 2004 1535 1548
11. L.A. Wolfraim, T.M. Fernandez, and M. Mamura Loss of Smad3 in acute T-cell lymphoblastic leukemia N Engl J Med 351 2004 552 559
12. C. Graux, J. Cools, and C. Melotte Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia Nat Genet 36 2004 1084 1089
13. K.E. Barber, M. Martineau, and L. Harewood Amplification of the ABL gene in T-cell acute lymphoblastic leukemia Leukemia 18 2004 1153 1156
14. A.P. Weng, A.A. Ferrando, and W. Lee Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia Science 306 2004 269 271
15. G.T. Wong, D. Manfra, and F.M. Poulet Chronic treatment with the γ-secretase inhibitor LY-411,575 inhibits β-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation J Biol Chem 279 2004 12876 12882
16. B.M. Jehn, I. Dittert, and S. Beyer c-Cbl binding and ubiquitin-dependent lysosomal degradation of membrane-associated Notch1 J Biol Chem 277 2002 8033 8040